Buyers are taking charge and building for the next leg higher

Potential Buy Entry Alert to Watch CUV

Time Frame : Daily/Weekly

Sector : Pharmaceuticals/Healthcare

Key Stats : $1.23 Billion Market Cap, VWAP 25.611, ASX Ranking 206, 4 Week Av Turnover $2,558,153, Current Turnover (Intraday as at time of alert) $2,144,675, PE 76.0.

Company Overview : Clinuvel Pharmaceuticals Limited (CUV) is a biopharmaceutical company focused on developing drugs for the treatment of a range of severe skin disorders. CUV’s lead compound is SCENESSE (afamelanotide), a drug targeting erythropoietic protoporphyria (EPP).

Broker Consensus : HOLD

CUV – Clinuvel Pharmaceuticals Limited

CUV has been on the rise since 2018 and looks set to continue the long term move up. We are watching now for some heat to come out of the latest rally from 21.00 up to current levels and for buyers to build the higher low for the buy entry setup.

Stock Code : CUV – Clinuvel Pharmaceuticals Limited

Company Website :

Current Price : 26.39

Status : On watch for potential higher low and move through 30.00